14,15-Dehydro Budesonide

Suppliers

Names

[ CAS No. ]:
131918-64-4

[ Name ]:
14,15-Dehydro Budesonide

[Synonym ]:
(4aR,4bS,5S,6aS,6bS,9aR,10bR)-6b-Glycoloyl-5-hydroxy-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10b,11,12-decahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
2H-Naphth[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one, 4a,4b,5,6,6a,6b,9a,10b,11,12-decahydro-5-hydroxy-6b-(2-hydroxyacetyl)-4a,6a-dimethyl-8-propyl-, (4aR,4bS,5S,6aS,6bS,9aR,10bR)-
Budesonide Impurity 5

Chemical & Physical Properties

[ Density]:
1.3±0.1 g/cm3

[ Boiling Point ]:
612.4±55.0 °C at 760 mmHg

[ Molecular Formula ]:
C25H32O6

[ Molecular Weight ]:
428.518

[ Flash Point ]:
207.6±25.0 °C

[ Exact Mass ]:
428.219879

[ PSA ]:
93.06000

[ LogP ]:
3.49

[ Vapour Pressure ]:
0.0±4.0 mmHg at 25°C

[ Index of Refraction ]:
1.607

Safety Information

[ Symbol ]:

GHS08

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H361-H373

[ Precautionary Statements ]:
P260-P280

[ Target Organs ]:
Endocrine system

[ RIDADR ]:
NONH for all modes of transport

Related Compounds

  • 14,15-dehydro leukotriene b4
  • 14,15-Dehydro Triamcinolone Acetonide
  • CHAPARRINONE,5-HYDROXY-14,15-DEHYDRO-
  • 14,15-Dehydrocrepenyic acid
  • 14,15-dehydrovincanol
  • 14,15-Leukotriene D4
  • N1-(4-fluorobenzyl)-N2-(3-hydroxy-3-(thiophen-3-yl)propyl)oxalamide
  • N1-(2,4-difluorophenyl)-N2-(3-hydroxy-3-(thiophen-3-yl)propyl)oxalamide
  • 1-(Bicyclo[2.2.1]heptan-2-yl)propan-1-amine
  • N1-(4-(dimethylamino)phenyl)-N2-(3-hydroxy-3-(thiophen-3-yl)propyl)oxalamide
  • [2-(2,2-Dimethylpropanoylamino)-3-fluorophenyl]boronic acid
  • (3,4-Difluoro-2-pivalamidophenyl)boronic acid
  • N1-(benzo[d][1,3]dioxol-5-yl)-N2-(3-hydroxy-3-(thiophen-3-yl)propyl)oxalamide
  • (2-Bromooxazol-5-yl)methanamine
  • N1-(3-hydroxy-3-(thiophen-3-yl)propyl)-N2-(2-(methylthio)phenyl)oxalamide
  • N1-(3-chloro-2-methylphenyl)-N2-(3-hydroxy-3-(thiophen-3-yl)propyl)oxalamide
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.